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Summary.-Levels of carcinoembryonic antigen (CEA) and glucose phosphate
isomerase (GPI) have been compared in the circulating blood of hamsters bearing
intra-muscular grafts of GW-39 human colonic tumour. CEA in the sera of GW-39
tumour-bearing hamsters ranged from 2 6 to 8-4 ng/ml (mean = 4-5 ± 1-7 ng/ml).
GPI in the sera ofnormal hamsters ranged from332 to749 iu/l (mean = 602 ± 110 iu/l)
while those with 14-week-old intra-muscular grafts of a hamster amelanotic
melanoma,(A.Mel.3), or GW-39humancolonic carcinomahad arange of664to 1267iu/l
(mean = 1024 + 220 iu/l) and 1430 to 4719 iu/l (mean - 2065 ± 601 iu/l) respectively.
Thus, the ratio of enzyme activity in GW-39, A.Mel.3, and normal hamsters was
3 4:1-7:1, indicating a significant elevation (P < 0.01) in animals bearing a human
colon carcinoma or a hamster melanoma, with particularly high values obtained in
hamsters with GW-39.
Sequential determinations of CEA and GPI in a group of hamsters transplanted
intra-muscularly with GW-39 tumours revealed that both markers increased pro-
portionately with duration of tumour growth, suggesting that both serum CEA and
GPI may be used as measures of tumour growth. The concentration of GPI in
GW-39 human colonic carcinoma xenografts was also significantly higher than that
measured in normal human colon, primary human colonic cancer, or normal hamster
tissues. These results support the view that GPI, in addition to CEA, is a quanti-
tatively increased marker in this tumour model, and is liberated into the circulation
in proportion to the increase in tumour mass.
TUMOUR ANTIGENS rarely, ifever, have
been found to be truly tumour- or organ-
specific (Laurence and Neville, 1972).
The carcinoembryonic antigen (CEA) of
Gold and Freedman (1965), although
originally considered to be specific for
digestive tract cancers, has likewise not
realized its potential as a specific diag-
nostic test for this cancer type (Hansen
et al., 1974; Zamcheck, 1974). Neverthe-
less, it has proved to be an important
stimulus in the search for other tumour
markers. Since earlier studies have in-
dicated that certain serum enzymes can be
significantly elevated in cancer patients
(Badenetal., 1971; Bodansky, 1954, 1974),
it was considered of interest to assess the
combined use of CEA and particular
serum enzymes as a possible improvement
over each modality by itself in the detec-
tion of cancer. Recent studies of cancer
patients have indeed shown that some of
these enzymes can increase diagnostic
accuracy in breast, lung and colorectal
cancers when combined with the plasma
CEA test (Steele et al., 1974; Cooper et al.,
1975; Mun.jal et al., 1976). As a corollary
to these initial clinical studies, we have
undertaken an evaluation of the circu-
lating levels of CEA and GPI in hamsters
bearing a xenografted human colonic
carcinoma, GW-39 (Goldenberg, Witte
and Elster, 1966), in order to study
certain relationships of these two putative
tumour markers in a human tumour
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MATERIALS AND METHODS
Tumours.-GW-39 tumours were pro-
pagated in the hind limb musculature of
unconditioned adult hamsters (Sprague-
Dawley, Madison, Wisc.) of both sexes,
weighing 60 to 80g. The tumours were
excised at regular intervals between 6 and
16 weeks. The tumour transplantation
technique is that of Goldenberg et al. (1966),
and consists ofinjecting 0-1 ml of a 10 to 20%
(w/v) tumour cell suspension into the growth
site. Expansively-growing, mucin-producing,
signet-ring-cell carcinomas result, in almost
all animals grafted. Ten hamsters bearing
Fortner's hamster amelanotic melanoma,
A.Mel.3 (Fortner, Mahy and Schrodt, 1961),
at the same growth site, as well as 25 un-
treated hamsters, served as controls. Another
group of 5 hamsters bearing intra-muscular
(i.m.) grafts of GW-39 was sequentially bled
by cardiac puncture up to 16 weeks after
transplantation.
Samplecollection.-The blood wascollected
by cardiac puncture and the serum was
separated. The same serum sample was used
for CEA and GPI tests. During bleeding,
care was taken to avoid haemolysis since
some blood components release, inhibit, or
activate the enzyme. Plasma samples were
avoided, since variable results have been
reported irrespective of the anticoagulant
used (Harrocks, Ward and King, 1963).
Tumour and normal tissue extractions.-
Tissues (lung, liver, colon, spleen and kidney)
from normal hamsters or GW-39 tumours
from tumour-bearing hamsters were collected
by sacrificing the animals. Normal and
malignant human tissue specimens were
obtained at surgery or autopsy. The tissues
were washed free of blood components with
ice-cold distilled water and necrotic parts, if
any, were dissected away. Pooled normal
tissues or GW-39 tumours were minced and
homogenized in 5 volumes (w/v) cold distilled
H20 in a Sorvall Omnimixer. Following
centrifugation for 30 min at 10,000 rev/min
at 40C, the pellets were rehomogenized in 3
volumes of cold distilled H20 and recentri-
fuged. The combined supernates were tested
for CEA, GPI and protein content.
Measurement of CEA and GPI levels.-
CEA in the serum (0-5 ml/specimen) was
measured by an indirect radioimmunoassay
using Hansen's Z-gel procedure (Hansen,
Lance and Krupey, 1971), with standard
reagents supplied by Hoffmann-La Roche,
Inc., Nutley, N.J. Appropriate standard
curves were made with normal hamster sera
and the samples were diluted in 0.9% NaCl
before extraction with equal volumes of
1 2M percholoric acid. Due to the relatively
larger serum quantity required for the CEA
assay, it was necessary to pool the serum
samples.
GPI activity in the serum (50 ,ul/speci-
men) was measured by the method of
Bueding and MacKinnon (1955), using stan-
dard reagents supplied by Worthington
Biochemical Corporation, Freehold, N.J.
Each animal's serum specimen was indi-
vidually assayed for GPI activity. GPI
catalyzes the isomerization of fructose-6-
phosphate to glucose-6-phosphate, which is
in turn oxidized to 6-phosphogluconate and
NADH in the presence ofglucose-6-phosphate
dehydrogenase and NAD. The NADH
produced in the second part ofthe reaction is
directly proportional to the glucose-6-phos-
phate produced in the first part of the
reaction, so that the rate of increase of
NADH measured at 340 nm is a measure of
GPI activity. One international unit (iu)
reduces 1 ,umol NAD per min at 30°C.
Protein.-Protein was quantitated by the
Lowry et al. (1951) procedure, using bovine
serum albumin as the reference standard.
The concentration of GPI in tissue extracts
was calculated as iu/g protein.
RESULTS
The results for GPI activity and CEA
in the sera of normal hamsters and
hamsters bearing i.m. grafts of A.Mel.3 or
GW-39 tumours are presented in Table I.
GPI activity in the sera of normal ham-
sters ranged from 332 to 749 iu/l, with a
mean of 602 + 100 iu/l. Hamsters bear-
ing 14-week-old i.m. grafts ofA.Mel.3 and
GW-39 human colonic carcinoma had
serum GPI values of 664 to 1267 iu/l (with
a mean of 1024 + 200 iu/l) and 1430 to
4719 iu/l (with a mean of2065 ± 601 iu/l),
respectively. Thus, the ratio of GPI in
the circulating blood of GW-39 animals,
A.Mel.3 animals, and normal hamsters is
3-4:1:7: 1. Levels of CEA in the sera of
hamsters bearing GW-39 tumours sacri-
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10 0-0 5 0 3
22 2-6-8-4 4-5±1-7
* Out of65hamsters with GW-39 tumours, 25 were sacrificed after 6 weeks, 15 after 10 weeks, and 25 after
14 weeks.
t CEA values were determined in circulating blood of hamsters bearing GW-39 tumours sacrificed aftei
6 weeks of transplantation. CEA measurements in the blood of normal hamsters are within the range of
sensitivity of the assay, thus being considered negative.
ficed 6 weeks after transplantation ranged
from 2-6 to 8-4 ng/ml (mean = 4-5 + 1P7
ng/ml) as compared to 0 to 045 ng/ml
(mean = 0 3 ng/ml) in sera of normal
hamsters. The ratio of mean CEA values
in sera of GW-39 tumour-bearing and
normal hamsters is 15: 1. Statistcially,
elevated CEA and GPI values are
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FIG. 1.-CEA and GPI values in hamster
blood in relation to time of tumour trans-
plantation. Each CEA determination
represents the mean of pooled sera from
5 hamsters.
Sequential determinations of GPI and
CEA in a small group of 5 hamsters
transplanted i.m. with GW-39 are shown
in Fig. 1. Both CEA and GPI increased
proportionately with the age ofthe tumour
after transplantation, thus reflecting the
expansive growth of the tumour. The
highest levels ofCEA and GPI (13.7 ng/ml
and 2325 iu/l, respectively) were attained
at 14 weeks after grafting. After this
time, the values declined to 8-5 ng/ml and
2100 iu/l for CEA and GPI, respectively,
at 16 weeks.
The concentrations of GPI in water
extracts of various tissue specimens are
shown in Table II. The mean GPI
activity in primary human colonic carci-
noma was approximately 3 times the
amount present in normal human colon
(P < 0.01). GW-39 tumour extracts
showed 8 to 9 times the GPI activity
found in normal hamster tissues, and 6 to
7 times the activity measured in primary
human colonic carcinoma (P < 0.01).
Normal hamster tissues, on average,
seemed to contain twice the GPI enzyme
activity of normal human colon.
TABLE II.-Concentration of GPI in Normal and Tumour Tissues
Tissue
Normal human colon
Primary human colonic carcinoma
GW-39 human colonic carcinoma transplant








10 210-750 558± 178
3 25-90 61±33
* Pooled organs obtained from a total of 6 animals.
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DISCUSSION
Previous reports have shown that the
GW-39 human colonic carcinoma serially
propagated in hamsters retains a number
of characteristics of its human and its
colonic origin, including the synthesis of
CEA (Goldenberg and Hansen, 1972;
Goldenberg et al., 1972) and a colon-
specific antigen, CSA (Goldenberg, Pegram
and Vazquez, 1975), even after a sojourn
in animal hosts for more than 10 years.
The current study has demonstrated that
both CEA and GPI can circulate in
increased quantities in the blood of
hamsters bearing i.m. grafts of GW-39
tumours, thus suggesting that both CEA
and GPI areindigenousto thetumour cells.
In the case of GPI, our experiments have
demonstrated a higher activity in GW-39
tumours as compared to either normal
hamster tissues, normal human colon, or
primary human colonic adenocarcinoma.
The significantly increased level of GPI
activity in GW-39 tumours, as compared
to primary human colonic cancer, raises
the question ofwhether our colonic cancer
xenograft may be more reflective of
metastatic than ofprimary colonic cancer,
although this tumour was originally
grafted directly from a specimen of
sigmoid colon adenocarcinoma (Golden-
berg et al., 1966). This view is supported
by the earlier findings of Cooper et al.
(1975) and Munjal et al. (1975, 1976) for
several other enzymes which, together
with CEA, were found to be considerably
elevated in the sera and tumour extracts
of patients with colorectal cancers meta-
static to the liver, and our own recent
observations that metastatic colonic
cancer has higher GPI activity than
primary colonic cancer (Munjal, Zam-
check, and Goldenberg, in preparation).
Several investigators have already
reported that serum GPI is often elevated
in patients with cancers of the digestive
tract (Schwartz et al., 1962), head and
neck (Schwartz, West and Zimmerman,
1962), lung (West et at., 1962), and breast
(Rose, West and Zimmerman, 1961). In
fact, Bodansky and others considered
GPI levels to be the best " index " of
malignancy many years ago (Bodansky,
1954; Griffith and Beck, 1963). The
presence of significantly increased serum
levels of GPI in hamsters bearing an
allogeneic melanoma would seem to sup-
port the contention that this enzyme
marker is increased in the circulation with
malignancy. Although this finding indi-
cates that an increase in GPI activity is
notrestricted to colonic cancer, it may well
be that quantitatively higher serumand/or
tumour values are present for colonic
cancer. A comparative study of sera and
tumour specimens from patients with
diverse types of cancer is therefore
indicated.
The gradual increase of circulating
CEA and GPI levels during the growth of
GW-39 tumours in the hamster, pre-
sumably reflecting an increase in tumour
mass, confirms clinical observations that
both these markers could be used as
indices of disease activity. For example,
CEA has been found to fall with complete
tumour resection and to rise with tumour
recurrence (Mach et at., 1974; Skarin et at.,
1974; Sorokin et al., 1974). In the
GW-39 tumour system, both circulating
CEA and GPI titres fall rapidly after
tumour resection (Munjal and Golden-
berg, 1976). In the hamster, the ratio of
CEA in the serum of tumour-bearing to
normal hamsters was between 40 and 50
at 14 weeks post-transplantation, whereas
the similar ratio for GPI was only about
5, thus indicating, at least in this mo(lel,
that more striking changes are experienced
with CEA than with GPI. The finding of
a concomitant increase in circulating CEA
and GPI in hamsters bearing a xeno-
grafted human colonic carcinoma does not,
by itself, indicate anyrelationship between
these 2 substances. Further work with
sequential determinations of both these
markers in relation to the clinical status
of the cancer patient need to be analysed
before a judgement can be made on
whether the combined use of CEA and
GPI in following patients with gastro-
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intestinal or other cancers is more reliable
than either parameter by itself.
An interesting observation in these
experiments was that after a certain
period of GW-39 tumour growth i.m.
(14 weeks), a fall in serum CEA and GPI
titresoccurred. Excessivetumour necrosis
would be expected to release more antigen
or enzyme into the circulation. A de-
creased clearance or degradation of circu-
lating CEA or GPI, if the animal's liver
functionwere compromised,wouldlikewise
result in higher rather than lower serum
levels of these substances. Hence, we are
encouraged to speculate that the hamster
may be forming immune complexes with
human CEA and GPI of the GW-39
tumour beyond a certain period of i.m.
growth, and that these complexes could
result in an apparent decrease in circu-
lating CEA or GPI levels. Indeed, other
evidence for circulating IgM antibody to
CEA in GW-39 tumour-bearing hamsters
has been obtained (Primus et at., 1976).
Further, a decision on whether there is
any relationship between CEA and GPI in
certain tumours must await the isolation
and characterization of these 2 tumour
markers in the GW-39 tumour system. It
is intriguing to speculate that GPI may
also prove to have different molecular
varieties in normal adult, fetal, and
malignant tissues, just as has been claimed
for CEA (Plow and Edgington, 1975; Rule
and Goleski-Reilly, 1973).
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